 | • レポートコード：MRC2-11QY04794 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、158ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は標的型ドラッグデリバリーサービスのグローバル市場について調査・分析したレポートです。種類別（目、脳、心臓、胸、腹部、その他）市場規模、用途別（代謝障害、眼科疾患、腫瘍性疾患、神経障害、心血管障害、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別標的型ドラッグデリバリーサービスの競争状況、市場シェア ・世界の標的型ドラッグデリバリーサービス市場：種類別市場規模 2015年-2020年（目、脳、心臓、胸、腹部、その他） ・世界の標的型ドラッグデリバリーサービス市場：種類別市場規模予測 2021年-2026年（目、脳、心臓、胸、腹部、その他） ・世界の標的型ドラッグデリバリーサービス市場：用途別市場規模 2015年-2020年（代謝障害、眼科疾患、腫瘍性疾患、神経障害、心血管障害、その他） ・世界の標的型ドラッグデリバリーサービス市場：用途別市場規模予測 2021年-2026年（代謝障害、眼科疾患、腫瘍性疾患、神経障害、心血管障害、その他） ・北米の標的型ドラッグデリバリーサービス市場分析：米国、カナダ ・ヨーロッパの標的型ドラッグデリバリーサービス市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの標的型ドラッグデリバリーサービス市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の標的型ドラッグデリバリーサービス市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの標的型ドラッグデリバリーサービス市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：4D Molecular Therapeutics、AbbVie、Abeona Therapeutics、Advaxis、Alcyone Lifesciences、AlphaVax、Amgen、Amicus Therapeutics、Anaeropharma Science、AnGes、AskBio、Astellas Pharma、AstraZeneca、Athersys、BioCardia、Biogen、BioInvent、BioRestorative Therapies、bluebird bio、Boston Scientific、CellProthera、Celsion、Celyad、Evonik、Kadimastem、Medtronic、Novartis、Sanofi、SOTIO、Takeda ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Targeted Drug Delivery Device is a method of delivery medication in some parts of the body. This means of delivery is largely founded on nanomedicine, which plans to employ nanoparticle-mediated drug delivery in order to combat the downfalls of conventional drug delivery. These nanoparticles would be loaded with drugs and targeted to specific parts where there is solely diseased tissue, thereby avoiding interaction with healthy tissue. The goal of the Targeted Drug Delivery is to prolong, localize, target and have a protected drug interaction with the diseased tissue. The conventional drug delivery system is the absorption of the drug across a biological membrane, whereas the targeted release system releases the drug in a dosage form. The advantages to the targeted release system is the reduction in the frequency of the dosages taken by the patient, having a more uniform effect of the drug, reduction of drug side-effects, and reduced fluctuation in circulating drug levels. The disadvantage of the system is high cost, which makes productivity more difficult and the reduced ability to adjust the dosages. (Wikipedia)
Market Analysis and Insights: Global Targeted Drug Delivery Device Market
The global Targeted Drug Delivery Device market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Targeted Drug Delivery Device market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Targeted Drug Delivery Device market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Targeted Drug Delivery Device market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Targeted Drug Delivery Device market.
Global Targeted Drug Delivery Device Scope and Segment
Targeted Drug Delivery Device market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Targeted Drug Delivery Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
by Target Organ
Eye
Brain
Heart
Breast
Abdomen
Others
by Type of Biologic Delivered
Cell
Protein
Enzyme
Plasmid
Antibody
Small Peptide
Modified RNA
Growth Factor
Neurotransmitter
by Therapy Delivered
Cell Therapy
RNA Therapy
Gene Therapy
Immunotherapy
Stem Cell Therapy
Market segment by Application, split into
Metabolic Disorder
Ophthalmic Disease
Oncological Disorder
Neurological Disorder
Cardiovascular Disorder
Others
Based on regional and country-level analysis, the Targeted Drug Delivery Device market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
In the competitive analysis section of the report, leading as well as prominent players of the global Targeted Drug Delivery Device market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
4D Molecular Therapeutics
AbbVie
Abeona Therapeutics
Advaxis
Alcyone Lifesciences
AlphaVax
Amgen
Amicus Therapeutics
Anaeropharma Science
AnGes
AskBio
Astellas Pharma
AstraZeneca
Athersys
BioCardia
Biogen
BioInvent
BioRestorative Therapies
bluebird bio
Boston Scientific
CellProthera
Celsion
Celyad
Evonik
Kadimastem
Medtronic
Novartis
Sanofi
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Targeted Drug Delivery Device Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 Eye
1.3.3 Brain
1.3.4 Heart
1.3.5 Breast
1.3.6 Abdomen
1.3.7 Others
1.4 Market by Application
1.4.1 Global Targeted Drug Delivery Device Market Share by Application: 2020 VS 2026
1.4.2 Metabolic Disorder
1.4.3 Ophthalmic Disease
1.4.4 Oncological Disorder
1.4.5 Neurological Disorder
1.4.6 Cardiovascular Disorder
1.4.7 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Drug Delivery Device Market Perspective (2015-2026)
2.2 Targeted Drug Delivery Device Growth Trends by Regions
2.2.1 Targeted Drug Delivery Device Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Targeted Drug Delivery Device Historic Market Share by Regions (2015-2020)
2.2.3 Targeted Drug Delivery Device Forecasted Market Size by Regions (2021-2026)
2.3 Targeted Drug Delivery Device Industry Dynamic
2.3.1 Targeted Drug Delivery Device Market Trends
2.3.2 Targeted Drug Delivery Device Market Drivers
2.3.3 Targeted Drug Delivery Device Market Challenges
2.3.4 Targeted Drug Delivery Device Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Drug Delivery Device Players by Market Size
3.1.1 Global Top Targeted Drug Delivery Device Players by Revenue (2015-2020)
3.1.2 Global Targeted Drug Delivery Device Revenue Market Share by Players (2015-2020)
3.2 Global Targeted Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Targeted Drug Delivery Device Revenue
3.4 Global Targeted Drug Delivery Device Market Concentration Ratio
3.4.1 Global Targeted Drug Delivery Device Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Drug Delivery Device Revenue in 2019
3.5 Key Players Targeted Drug Delivery Device Area Served
3.6 Key Players Targeted Drug Delivery Device Product Solution and Service
3.7 Date of Enter into Targeted Drug Delivery Device Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Drug Delivery Device Breakdown Data by Type
4.1 Global Targeted Drug Delivery Device Historic Market Size by Type (2015-2020)
4.2 Global Targeted Drug Delivery Device Forecasted Market Size by Type (2021-2026)
5 Targeted Drug Delivery Device Breakdown Data by Application
5.1 Global Targeted Drug Delivery Device Historic Market Size by Application (2015-2020)
5.2 Global Targeted Drug Delivery Device Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Targeted Drug Delivery Device Market Size (2015-2026)
6.2 North America Targeted Drug Delivery Device Market Size by Type (2015-2020)
6.3 North America Targeted Drug Delivery Device Market Size by Application (2015-2020)
6.4 North America Targeted Drug Delivery Device Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Targeted Drug Delivery Device Market Size (2015-2026)
7.2 Europe Targeted Drug Delivery Device Market Size by Type (2015-2020)
7.3 Europe Targeted Drug Delivery Device Market Size by Application (2015-2020)
7.4 Europe Targeted Drug Delivery Device Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Targeted Drug Delivery Device Market Size (2015-2026)
8.2 Asia-Pacific Targeted Drug Delivery Device Market Size by Type (2015-2020)
8.3 Asia-Pacific Targeted Drug Delivery Device Market Size by Application (2015-2020)
8.4 Asia-Pacific Targeted Drug Delivery Device Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Targeted Drug Delivery Device Market Size (2015-2026)
9.2 Latin America Targeted Drug Delivery Device Market Size by Type (2015-2020)
9.3 Latin America Targeted Drug Delivery Device Market Size by Application (2015-2020)
9.4 Latin America Targeted Drug Delivery Device Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Drug Delivery Device Market Size (2015-2026)
10.2 Middle East & Africa Targeted Drug Delivery Device Market Size by Type (2015-2020)
10.3 Middle East & Africa Targeted Drug Delivery Device Market Size by Application (2015-2020)
10.4 Middle East & Africa Targeted Drug Delivery Device Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 4D Molecular Therapeutics
11.1.1 4D Molecular Therapeutics Company Details
11.1.2 4D Molecular Therapeutics Business Overview
11.1.3 4D Molecular Therapeutics Targeted Drug Delivery Device Introduction
11.1.4 4D Molecular Therapeutics Revenue in Targeted Drug Delivery Device Business (2015-2020))
11.1.5 4D Molecular Therapeutics Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Targeted Drug Delivery Device Introduction
11.2.4 AbbVie Revenue in Targeted Drug Delivery Device Business (2015-2020)
11.2.5 AbbVie Recent Development
11.3 Abeona Therapeutics
11.3.1 Abeona Therapeutics Company Details
11.3.2 Abeona Therapeutics Business Overview
11.3.3 Abeona Therapeutics Targeted Drug Delivery Device Introduction
11.3.4 Abeona Therapeutics Revenue in Targeted Drug Delivery Device Business (2015-2020)
11.3.5 Abeona Therapeutics Recent Development
11.4 Advaxis
11.4.1 Advaxis Company Details
11.4.2 Advaxis Business Overview
11.4.3 Advaxis Targeted Drug Delivery Device Introduction
11.4.4 Advaxis Revenue in Targeted Drug Delivery Device Business (2015-2020)
11.4.5 Advaxis Recent Development
11.5 Alcyone Lifesciences
11.5.1 Alcyone Lifesciences Company Details
11.5.2 Alcyone Lifesciences Business Overview
11.5.3 Alcyone Lifesciences Targeted Drug Delivery Device Introduction
11.5.4 Alcyone Lifesciences Revenue in Targeted Drug Delivery Device Business (2015-2020)
11.5.5 Alcyone Lifesciences Recent Development
11.6 AlphaVax
11.6.1 AlphaVax Company Details
11.6.2 AlphaVax Business Overview
11.6.3 AlphaVax Targeted Drug Delivery Device Introduction
11.6.4 AlphaVax Revenue in Targeted Drug Delivery Device Business (2015-2020)
11.6.5 AlphaVax Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Targeted Drug Delivery Device Introduction
11.7.4 Amgen Revenue in Targeted Drug Delivery Device Business (2015-2020)
11.7.5 Amgen Recent Development
11.8 Amicus Therapeutics
11.8.1 Amicus Therapeutics Company Details
11.8.2 Amicus Therapeutics Business Overview
11.8.3 Amicus Therapeutics Targeted Drug Delivery Device Introduction
11.8.4 Amicus Therapeutics Revenue in Targeted Drug Delivery Device Business (2015-2020)
11.8.5 Amicus Therapeutics Recent Development
11.9 Anaeropharma Science
11.9.1 Anaeropharma Science Company Details
11.9.2 Anaeropharma Science Business Overview
11.9.3 Anaeropharma Science Targeted Drug Delivery Device Introduction
11.9.4 Anaeropharma Science Revenue in Targeted Drug Delivery Device Business (2015-2020)
11.9.5 Anaeropharma Science Recent Development
11.10 AnGes
11.10.1 AnGes Company Details
11.10.2 AnGes Business Overview
11.10.3 AnGes Targeted Drug Delivery Device Introduction
11.10.4 AnGes Revenue in Targeted Drug Delivery Device Business (2015-2020)
11.10.5 AnGes Recent Development
11.11 AskBio
10.11.1 AskBio Company Details
10.11.2 AskBio Business Overview
10.11.3 AskBio Targeted Drug Delivery Device Introduction
10.11.4 AskBio Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.11.5 AskBio Recent Development
11.12 Astellas Pharma
10.12.1 Astellas Pharma Company Details
10.12.2 Astellas Pharma Business Overview
10.12.3 Astellas Pharma Targeted Drug Delivery Device Introduction
10.12.4 Astellas Pharma Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.12.5 Astellas Pharma Recent Development
11.13 AstraZeneca
10.13.1 AstraZeneca Company Details
10.13.2 AstraZeneca Business Overview
10.13.3 AstraZeneca Targeted Drug Delivery Device Introduction
10.13.4 AstraZeneca Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.13.5 AstraZeneca Recent Development
11.14 Athersys
10.14.1 Athersys Company Details
10.14.2 Athersys Business Overview
10.14.3 Athersys Targeted Drug Delivery Device Introduction
10.14.4 Athersys Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.14.5 Athersys Recent Development
11.15 BioCardia
10.15.1 BioCardia Company Details
10.15.2 BioCardia Business Overview
10.15.3 BioCardia Targeted Drug Delivery Device Introduction
10.15.4 BioCardia Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.15.5 BioCardia Recent Development
11.16 Biogen
10.16.1 Biogen Company Details
10.16.2 Biogen Business Overview
10.16.3 Biogen Targeted Drug Delivery Device Introduction
10.16.4 Biogen Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.16.5 Biogen Recent Development
11.17 BioInvent
10.17.1 BioInvent Company Details
10.17.2 BioInvent Business Overview
10.17.3 BioInvent Targeted Drug Delivery Device Introduction
10.17.4 BioInvent Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.17.5 BioInvent Recent Development
11.18 BioRestorative Therapies
10.18.1 BioRestorative Therapies Company Details
10.18.2 BioRestorative Therapies Business Overview
10.18.3 BioRestorative Therapies Targeted Drug Delivery Device Introduction
10.18.4 BioRestorative Therapies Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.18.5 BioRestorative Therapies Recent Development
11.19 bluebird bio
10.19.1 bluebird bio Company Details
10.19.2 bluebird bio Business Overview
10.19.3 bluebird bio Targeted Drug Delivery Device Introduction
10.19.4 bluebird bio Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.19.5 bluebird bio Recent Development
11.20 Boston Scientific
10.20.1 Boston Scientific Company Details
10.20.2 Boston Scientific Business Overview
10.20.3 Boston Scientific Targeted Drug Delivery Device Introduction
10.20.4 Boston Scientific Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.20.5 Boston Scientific Recent Development
11.21 CellProthera
10.21.1 CellProthera Company Details
10.21.2 CellProthera Business Overview
10.21.3 CellProthera Targeted Drug Delivery Device Introduction
10.21.4 CellProthera Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.21.5 CellProthera Recent Development
11.22 Celsion
10.22.1 Celsion Company Details
10.22.2 Celsion Business Overview
10.22.3 Celsion Targeted Drug Delivery Device Introduction
10.22.4 Celsion Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.22.5 Celsion Recent Development
11.23 Celyad
10.23.1 Celyad Company Details
10.23.2 Celyad Business Overview
10.23.3 Celyad Targeted Drug Delivery Device Introduction
10.23.4 Celyad Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.23.5 Celyad Recent Development
11.24 Evonik
10.24.1 Evonik Company Details
10.24.2 Evonik Business Overview
10.24.3 Evonik Targeted Drug Delivery Device Introduction
10.24.4 Evonik Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.24.5 Evonik Recent Development
11.25 Kadimastem
10.25.1 Kadimastem Company Details
10.25.2 Kadimastem Business Overview
10.25.3 Kadimastem Targeted Drug Delivery Device Introduction
10.25.4 Kadimastem Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.25.5 Kadimastem Recent Development
11.26 Medtronic
10.26.1 Medtronic Company Details
10.26.2 Medtronic Business Overview
10.26.3 Medtronic Targeted Drug Delivery Device Introduction
10.26.4 Medtronic Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.26.5 Medtronic Recent Development
11.27 Novartis
10.27.1 Novartis Company Details
10.27.2 Novartis Business Overview
10.27.3 Novartis Targeted Drug Delivery Device Introduction
10.27.4 Novartis Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.27.5 Novartis Recent Development
11.28 Sanofi
10.28.1 Sanofi Company Details
10.28.2 Sanofi Business Overview
10.28.3 Sanofi Targeted Drug Delivery Device Introduction
10.28.4 Sanofi Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.28.5 Sanofi Recent Development
11.29 SOTIO
10.29.1 SOTIO Company Details
10.29.2 SOTIO Business Overview
10.29.3 SOTIO Targeted Drug Delivery Device Introduction
10.29.4 SOTIO Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.29.5 SOTIO Recent Development
11.30 Takeda
10.30.1 Takeda Company Details
10.30.2 Takeda Business Overview
10.30.3 Takeda Targeted Drug Delivery Device Introduction
10.30.4 Takeda Revenue in Targeted Drug Delivery Device Business (2015-2020)
10.30.5 Takeda Recent Development
12Analyst’s Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Targeted Drug Delivery Device Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of Eye
Table 3. Key Players of Brain
Table 4. Key Players of Heart
Table 5. Key Players of Breast
Table 6. Key Players of Abdomen
Table 7. Key Players of Others
Table 8. Global Targeted Drug Delivery Device Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Targeted Drug Delivery Device Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Targeted Drug Delivery Device Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Targeted Drug Delivery Device Market Share by Regions (2015-2020)
Table 12. Global Targeted Drug Delivery Device Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Targeted Drug Delivery Device Market Share by Regions (2021-2026)
Table 14. Targeted Drug Delivery Device Market Market Trends
Table 15. Targeted Drug Delivery Device Market Drivers
Table 16. Targeted Drug Delivery Device Market Challenges
Table 17. Targeted Drug Delivery Device Market Restraints
Table 18. Global Targeted Drug Delivery Device Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Targeted Drug Delivery Device Market Share by Players (2015-2020)
Table 20. Global Top Targeted Drug Delivery Device Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug Delivery Device as of 2019)
Table 21. Global Targeted Drug Delivery Device by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Targeted Drug Delivery Device Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Targeted Drug Delivery Device Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Targeted Drug Delivery Device Revenue Market Share by Type (2015-2020)
Table 27. Global Targeted Drug Delivery Device Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 28. Global Targeted Drug Delivery Device Market Size Share by Application (2015-2020) (US$ Million)
Table 29. Global Targeted Drug Delivery Device Revenue Market Share by Application (2015-2020)
Table 30. Global Targeted Drug Delivery Device Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 31. North America Targeted Drug Delivery Device Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Targeted Drug Delivery Device Market Share by Type (2015-2020)
Table 33. North America Targeted Drug Delivery Device Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Targeted Drug Delivery Device Market Share by Application (2015-2020)
Table 35. North America Targeted Drug Delivery Device Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Targeted Drug Delivery Device Market Share by Country (2015-2020)
Table 37. Europe Targeted Drug Delivery Device Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Targeted Drug Delivery Device Market Share by Type (2015-2020)
Table 39. Europe Targeted Drug Delivery Device Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Targeted Drug Delivery Device Market Share by Application (2015-2020)
Table 41. Europe Targeted Drug Delivery Device Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Targeted Drug Delivery Device Market Share by Country (2015-2020)
Table 43. Asia-Pacific Targeted Drug Delivery Device Market Size by Type (2015-2020) (US$ Million)
Table 44. Asia-Pacific Targeted Drug Delivery Device Market Share by Type (2015-2020)
Table 45. Asia-Pacific Targeted Drug Delivery Device Market Size by Application (2015-2020) (US$ Million)
Table 46. Asia-Pacific Targeted Drug Delivery Device Market Share by Application (2015-2020)
Table 47. Asia-Pacific Targeted Drug Delivery Device Market Size by Region (US$ Million) (2015-2020)
Table 48. Asia-Pacific Targeted Drug Delivery Device Market Share by Region (2015-2020)
Table 49. Latin America Targeted Drug Delivery Device Market Size by Type (2015-2020) (US$ Million)
Table 50. Latin America Targeted Drug Delivery Device Market Share by Type (2015-2020)
Table 51. Latin America Targeted Drug Delivery Device Market Size by Application (2015-2020) (US$ Million)
Table 52. Latin America Targeted Drug Delivery Device Market Share by Application (2015-2020)
Table 53. Latin America Targeted Drug Delivery Device Market Size by Country (US$ Million) (2015-2020)
Table 54. Latin America Targeted Drug Delivery Device Market Share by Country (2015-2020)
Table 55. Middle East & Africa Targeted Drug Delivery Device Market Size by Type (2015-2020) (US$ Million)
Table 56. Middle East & Africa Targeted Drug Delivery Device Market Share by Type (2015-2020)
Table 57. Middle East & Africa Targeted Drug Delivery Device Market Size by Application (2015-2020) (US$ Million)
Table 58. Middle East & Africa Targeted Drug Delivery Device Market Share by Application (2015-2020)
Table 59. Middle East & Africa Targeted Drug Delivery Device Market Size by Country (US$ Million) (2015-2020)
Table 60. Middle East & Africa Targeted Drug Delivery Device Market Share by Country (2015-2020)
Table 61. 4D Molecular Therapeutics Company Details
Table 62. 4D Molecular Therapeutics Business Overview
Table 63. 4D Molecular Therapeutics Targeted Drug Delivery Device Product
Table 64. 4D Molecular Therapeutics Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 65. 4D Molecular Therapeutics Recent Development
Table 66. AbbVie Company Details
Table 67. AbbVie Business Overview
Table 68. AbbVie Targeted Drug Delivery Device Product
Table 69. AbbVie Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 70. AbbVie Recent Development
Table 71. Abeona Therapeutics Company Details
Table 72. Abeona Therapeutics Business Overview
Table 73. Abeona Therapeutics Targeted Drug Delivery Device Product
Table 74. Abeona Therapeutics Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 75. Abeona Therapeutics Recent Development
Table 76. Advaxis Company Details
Table 77. Advaxis Business Overview
Table 78. Advaxis Targeted Drug Delivery Device Product
Table 79. Advaxis Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 80. Advaxis Recent Development
Table 81. Alcyone Lifesciences Company Details
Table 82. Alcyone Lifesciences Business Overview
Table 83. Alcyone Lifesciences Targeted Drug Delivery Device Product
Table 84. Alcyone Lifesciences Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 85. Alcyone Lifesciences Recent Development
Table 86. AlphaVax Company Details
Table 87. AlphaVax Business Overview
Table 88. AlphaVax Targeted Drug Delivery Device Product
Table 89. AlphaVax Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 90. AlphaVax Recent Development
Table 91. Amgen Company Details
Table 92. Amgen Business Overview
Table 93. Amgen Targeted Drug Delivery Device Product
Table 94. Amgen Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 95. Amgen Recent Development
Table 96. Amicus Therapeutics Business Overview
Table 97. Amicus Therapeutics Targeted Drug Delivery Device Product
Table 98. Amicus Therapeutics Company Details
Table 99. Amicus Therapeutics Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 100. Amicus Therapeutics Recent Development
Table 101. Anaeropharma Science Company Details
Table 102. Anaeropharma Science Business Overview
Table 103. Anaeropharma Science Targeted Drug Delivery Device Product
Table 104. Anaeropharma Science Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 105. Anaeropharma Science Recent Development
Table 106. AnGes Company Details
Table 107. AnGes Business Overview
Table 108. AnGes Targeted Drug Delivery Device Product
Table 109. AnGes Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 110. AnGes Recent Development
Table 111. AskBio Company Details
Table 112. AskBio Business Overview
Table 113. AskBio Targeted Drug Delivery Device Product
Table 114. AskBio Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 115. AskBio Recent Development
Table 116. Astellas Pharma Company Details
Table 117. Astellas Pharma Business Overview
Table 118. Astellas Pharma Targeted Drug Delivery Device Product
Table 119. Astellas Pharma Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 120. Astellas Pharma Recent Development
Table 121. AstraZeneca Company Details
Table 122. AstraZeneca Business Overview
Table 123. AstraZeneca Targeted Drug Delivery Device Product
Table 124. AstraZeneca Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 125. AstraZeneca Recent Development
Table 126. Athersys Company Details
Table 127. Athersys Business Overview
Table 128. Athersys Targeted Drug Delivery Device Product
Table 129. Athersys Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 130. Athersys Recent Development
Table 131. BioCardia Company Details
Table 132. BioCardia Business Overview
Table 133. BioCardia Targeted Drug Delivery Device Product
Table 134. BioCardia Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 135. BioCardia Recent Development
Table 136. Biogen Company Details
Table 137. Biogen Business Overview
Table 138. Biogen Targeted Drug Delivery Device Product
Table 139. Biogen Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 140. Biogen Recent Development
Table 141. BioInvent Company Details
Table 142. BioInvent Business Overview
Table 143. BioInvent Targeted Drug Delivery Device Product
Table 144. BioInvent Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 145. BioInvent Recent Development
Table 146. BioRestorative Therapies Company Details
Table 147. BioRestorative Therapies Business Overview
Table 148. BioRestorative Therapies Targeted Drug Delivery Device Product
Table 149. BioRestorative Therapies Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 150. BioRestorative Therapies Recent Development
Table 151. bluebird bio Company Details
Table 152. bluebird bio Business Overview
Table 153. bluebird bio Targeted Drug Delivery Device Product
Table 154. bluebird bio Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 155. bluebird bio Recent Development
Table 156. Boston Scientific Company Details
Table 157. Boston Scientific Business Overview
Table 158. Boston Scientific Targeted Drug Delivery Device Product
Table 159. Boston Scientific Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 160. Boston Scientific Recent Development
Table 161. CellProthera Company Details
Table 162. CellProthera Business Overview
Table 163. CellProthera Targeted Drug Delivery Device Product
Table 164. CellProthera Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 165. CellProthera Recent Development
Table 166. Celsion Company Details
Table 167. Celsion Business Overview
Table 168. Celsion Targeted Drug Delivery Device Product
Table 169. Celsion Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 170. Celsion Recent Development
Table 171. Celyad Company Details
Table 172. Celyad Business Overview
Table 173. Celyad Targeted Drug Delivery Device Product
Table 174. Celyad Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 175. Celyad Recent Development
Table 176. Evonik Company Details
Table 177. Evonik Business Overview
Table 178. Evonik Targeted Drug Delivery DeviceProduct
Table 179. Evonik Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 180. Evonik Recent Development
Table 181. Kadimastem Company Details
Table 182. Kadimastem Business Overview
Table 183. Kadimastem Targeted Drug Delivery Device Product
Table 184. Kadimastem Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 185. Kadimastem Recent Development
Table 186. Medtronic Company Details
Table 187. Medtronic Business Overview
Table 188. Medtronic Targeted Drug Delivery Device Product
Table 189. Medtronic Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 190. Medtronic Recent Development
Table 191. Novartis Company Details
Table 192. Novartis Business Overview
Table 193. Novartis Targeted Drug Delivery Device Product
Table 194. Novartis Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 195. Novartis Recent Development
Table 196. Sanofi Company Details
Table 197. Sanofi Business Overview
Table 198. Sanofi Targeted Drug Delivery Device Product
Table 199. Sanofi Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 200. Sanofi Recent Development
Table 201. SOTIO Company Details
Table 202. SOTIO Business Overview
Table 203. SOTIO Targeted Drug Delivery Device Product
Table 204. SOTIO Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 205. SOTIO Recent Development
Table 206. Takeda Company Details
Table 207. Takeda Business Overview
Table 208. Takeda Targeted Drug Delivery Device Product
Table 209. Takeda Revenue in Targeted Drug Delivery Device Business (2015-2020) (US$ Million)
Table 210. Takeda Recent Development
Table 211. Research Programs/Design for This Report
Table 212. Key Data Information from Secondary Sources
Table 213. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Drug Delivery Device Market Share by Type: 2020 VS 2026
Figure 2. Eye Features
Figure 3. Brain Features
Figure 4. Heart Features
Figure 5. Breast Features
Figure 6. Abdomen Features
Figure 7. Others Features
Figure 8. Global Targeted Drug Delivery Device Market Share by Application: 2020 VS 2026
Figure 9. Metabolic Disorder Case Studies
Figure 10. Ophthalmic Disease Case Studies
Figure 11. Oncological Disorder Case Studies
Figure 12. Neurological Disorder Case Studies
Figure 13. Cardiovascular Disorder Case Studies
Figure 14. Others Case Studies
Figure 15. Targeted Drug Delivery Device Report Years Considered
Figure 16. Global Targeted Drug Delivery Device Market Size (US$ Million), YoY Growth 2015-2026
Figure 17. Global Targeted Drug Delivery Device Market Share by Regions: 2020 VS 2026
Figure 18. Global Targeted Drug Delivery Device Market Share by Regions (2021-2026)
Figure 19. Global Targeted Drug Delivery Device Market Share by Players in 2019
Figure 20. Global Top Targeted Drug Delivery Device Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug Delivery Device as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Targeted Drug Delivery Device Revenue in 2019
Figure 22. North America Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. United States Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Canada Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Europe Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Germany Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. France Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. U.K. Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Italy Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Russia Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Nordic Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Asia-Pacific Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. China Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Japan Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. South Korea Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Southeast Asia Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. India Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Australia Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Rest of Asia-Pacific Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Latin America Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Mexico Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Brazil Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Middle East & Africa Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Turkey Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Saudi Arabia Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. UAE Targeted Drug Delivery Device Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. 4D Molecular Therapeutics Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 48. AbbVie Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 49. Abeona Therapeutics Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 50. Advaxis Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 51. Alcyone Lifesciences Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 52. AlphaVax Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 53. Amgen Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 54. Amicus Therapeutics Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 55. Anaeropharma Science Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 56. AnGes Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 57. AskBio Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 58. Astellas Pharma Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 59. AstraZeneca Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 60. Athersys Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 61. BioCardia Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 62. Biogen Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 63. BioInvent Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 64. BioRestorative Therapies Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 65. bluebird bio Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 66. Boston Scientific Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 67. CellProthera Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 68. Celsion Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 69. Celyad Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 70. Evonik Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 71. Kadimastem Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 72. Medtronic Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 73. Novartis Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 74. Sanofi Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 75. SOTIO Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 76. Takeda Revenue Growth Rate in Targeted Drug Delivery Device Business (2015-2020)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
糖尿病性神経障害治療薬の世界市場（～2026年） A drug used to treat mental illness caused by diabetes Market Analysis and Insights: Global Diabetic Neurological Disorder Therapeutic Drug Market The global Diabetic Neurological Disorder Therapeutic Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CA…- 胃運動障害治療薬の世界市場（～2026年） Market Analysis and Insights: Global Gastric Motility Disorder Drug Market The global Gastric Motility Disorder Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gastric Motility Disorder Drug Scope and Market Size …
- ターゲットデリバリドラッグの世界市場（～2026年） Targeted delivery of drugs is defined as a method of injecting drugs into the body so that they only target specific parts of the body. Targeted delivery of drugs is designed to target, extend and protect interactions with diseased tissues. Market Analysis and Insights: Global Targeted Delivery Drug…
- 神経障害治療薬の世界市場（～2026年） Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson’s Disease Association, in Europe is actively su…
- 過食症治療薬の世界市場（～2026年） Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusuall…